BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
Hospital Universitario de Getafe
Getafe, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Getafe (20)
2023
-
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Blood Cancer Journal
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series
Gastroenterologia y Hepatologia
2022
-
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS
Frontiers in Immunology, Vol. 13
2021
-
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
PLoS ONE, Vol. 16, Núm. 9 September
-
Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality
Heart, Vol. 107, Núm. 6, pp. 497-502
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
2020
-
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. e513-e522
2018
-
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy
Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331
-
Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project
Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96
-
Reliability and validity of the Spanish version of the IDEAL Schedule for assessing care needs in dementia: Cross-sectional, multicenter study
International Journal of Geriatric Psychiatry, Vol. 33, Núm. 3, pp. 482-488
2012
2010
-
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era
European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328
-
Lesiones importadas del sistema nervioso
Medicine, Vol. 10, Núm. 55, pp. 3780-3784
2008
-
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: A prospective study from the GEL-TAMO study group
European Journal of Haematology, Vol. 80, Núm. 3, pp. 227-235
2007
-
Sucesos adversos en cirugía general y de aparato digestivo en los hospitales españoles
Cirugia Espanola, Vol. 82, Núm. 5, pp. 268-277
-
Un aspecto crítico de la calidad: Los sucesos adversos en los hospitales españoles: Resultados del estudio eneas
Medicina Preventiva, Vol. 13, Núm. SPEC. ISS., pp. 64-70
2006
-
Erratum: Rituximab in the management of chronic immune thrombocytopenic purpura: An effective and safe therapeutic alternative in refractory patients (Annals Hematology (2006) 10.1007/s00277-005-0073-1)
Annals of Hematology
-
Rituximab in the management of chronic immune thrombocytopenic purpura: An effective and safe therapeutic alternative in refractory patients
Annals of Hematology, Vol. 85, Núm. 6, pp. 400-406